XML 17 R8.htm IDEA: XBRL DOCUMENT
v3.23.2

General | 6 Months Ended
--- | ---
Jun. 29, 2023
Accounting Policies [Abstract] |
General | General Basis of Presentation - The unaudited consolidated financial statements for the 13 and 26 weeks ended June 29, 2023 and June 30, 2022 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at June 29, 2023, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 29, 2022. Accounting Policies - Refer to the Company’s audited consolidated financial statements (including footnotes) for the fiscal year ended December 29, 2022, contained in the Company’s Annual Report on Form 10-K for such year, for a description of the Company’s accounting policies. Noncontrolling Interest - The Company has an ownership interest greater than 50% in one joint venture that is considered a Variable Interest Entity (VIE) that is included in the accounts of the Company. The Company is the primary beneficiary of the VIE and the Company’s interest is considered a majority voting interest. The primary asset of this VIE, The Skirvin Hilton, was sold on December 16, 2022. The equity interest of outside owners in consolidated entities is recorded as noncontrolling interest in the consolidated balance sheets. Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $15,986 and $31,854 for the 13 and 26 weeks ended June 29, 2023, respectively, and $16,744 and $33,967 for the 13 and 26 weeks ended June 30, 2022, respectively. Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset. As of June 29, 2023, assets held for sale consists of excess land. Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value. There were no indicators of impairment identified during the 26 weeks ended June 29, 2023 or June 30, 2022. Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 26 weeks ended June 29, 2023 or June 30, 2022. Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares. Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends. The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share and provides a reconciliation of the number of weighted-average basic and diluted shares outstanding:
| 13 Weeks Ended |  | 26 Weeks Ended
| June 29, 2023 |  | June 30, 2022 |  | June 29, 2023 |  | June 30, 2022
Numerator: |  |  |  |  |  |  |
Net earnings (loss) | $ | 13,466 |  |  | $ | 8,960 |  |  | $ | 4,000 |  |  | $ | (5,942) |
Denominator (in thousands): |  |  |  |  |  |  |
Denominator for basic EPS | 31,673 |  |  | 31,492 |  |  | 31,622 |  |  | 31,469 |
Effect of dilutive employee stock options | 61 |  |  | 40 |  |  | 52 |  |  | — |
Effect of convertible notes | 9,201 |  |  | 9,085 |  |  | — |  |  | — |
Denominator for diluted EPS | 40,935 |  |  | 40,617 |  |  | 31,674 |  |  | 31,469 |
Net earnings (loss) per share - basic: |  |  |  |  |  |  |
Common Stock | $ | 0.43 |  |  | $ | 0.29 |  |  | $ | 0.13 |  |  | $ | (0.19) |
Class B Common Stock | $ | 0.39 |  |  | $ | 0.26 |  |  | $ | 0.12 |  |  | $ | (0.18) |
Net earnings (loss) per share - diluted: |  |  |  |  |  |  |
Common Stock | $ | 0.35 |  |  | $ | 0.24 |  |  | $ | 0.13 |  |  | $ | (0.19) |
Class B Common Stock | $ | 0.34 |  |  | $ | 0.23 |  |  | $ | 0.12 |  |  | $ | (0.18) |
For the periods when the Company reports a net loss, common stock equivalents are excluded from the computation of diluted loss per share as their inclusion would have an antidilutive effect. During the 26 weeks ended June 30, 2022, approximately 61,791 common stock equivalents were excluded from the computation of diluted loss per share due to the Company’s net loss. During the 26 weeks ended June 29, 2023, and June 30, 2022, respectively, 9,200,907 and 9,084,924 shares related to the convertible notes were excluded from the computation of diluted loss per share as the effect would have been anti-dilutive. Shareholders’ Equity - Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 13 and 26 weeks ended June 29, 2023 and June 30, 2022 was as follows:
| Common Stock |  | Class B Common Stock |  | Capital in Excess of Par |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Treasury Stock |  | Shareholders’ Equity Attributable to The Marcus Corporation |  | Non- controlling Interest |  | Total Equity
BALANCES AT DECEMBER 29, 2022 | $ | 24,498 |  |  | $ | 7,111 |  |  | $ | 153,794 |  |  | $ | 274,254 |  |  | $ | (1,694) |  |  | $ | (1,866) |  |  | $ | 456,097 |  |  | $ | 824 |  |  | $ | 456,921 |
Cash dividends: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
$0.045 per share Class B Common Stock | — |  |  | — |  |  | — |  |  | (319) |  |  | — |  |  | — |  |  | (319) |  |  | — |  |  | (319) |
$0.05 per share Common Stock | — |  |  | — |  |  | — |  |  | (1,229) |  |  | — |  |  | — |  |  | (1,229) |  |  | — |  |  | (1,229) |
Exercise of stock options | — |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | 3 |  |  | 2 |  |  | — |  |  | 2 |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (313) |  |  | (313) |  |  | — |  |  | (313) |
Savings and profit-sharing contribution | 79 |  |  | — |  |  | 1,180 |  |  | — |  |  | — |  |  | — |  |  | 1,259 |  |  | — |  |  | 1,259 |
Reissuance of treasury stock | — |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | 24 |  |  | 21 |  |  | — |  |  | 21 |
Issuance of non-vested stock | 82 |  |  | — |  |  | (143) |  |  | — |  |  | — |  |  | 61 |  |  | — |  |  | — |  |  | — |
Shared-based compensation | — |  |  | — |  |  | 2,172 |  |  | — |  |  | — |  |  | — |  |  | 2,172 |  |  | — |  |  | 2,172 |
Other | — |  |  | — |  |  | 1 |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Conversions of Class B Common Stock | 33 |  |  | (33) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Distribution to noncontrolling interest | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (550) |  |  | (550) |
Comprehensive loss | — |  |  | — |  |  | — |  |  | (9,466) |  |  | (91) |  |  | — |  |  | (9,557) |  |  | — |  |  | (9,557) |
BALANCES AT MARCH 30, 2023 | $ | 24,692 |  |  | $ | 7,078 |  |  | $ | 157,000 |  |  | $ | 263,239 |  |  | $ | (1,785) |  |  | $ | (2,091) |  |  | $ | 448,133 |  |  | $ | 274 |  |  | $ | 448,407 |
Cash dividends: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
$0.045 per share Class B Common Stock | — |  |  | — |  |  | — |  |  | (319) |  |  | — |  |  | — |  |  | (319) |  |  | — |  |  | (319) |
$0.05 per share Common Stock | — |  |  | — |  |  | — |  |  | (1,230) |  |  | — |  |  | — |  |  | (1,230) |  |  | — |  |  | (1,230) |
Exercise of stock options | — |  |  | — |  |  | (25) |  |  | — |  |  | — |  |  | 121 |  |  | 96 |  |  | — |  |  | 96 |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (226) |  |  | (226) |  |  | — |  |  | (226) |
Reissuance of treasury stock | — |  |  | — |  |  | (204) |  |  | — |  |  | — |  |  | 223 |  |  | 19 |  |  | — |  |  | 19 |
Issuance of non-vested stock | — |  |  | — |  |  | (55) |  |  | — |  |  | — |  |  | 55 |  |  | — |  |  | — |  |  | — |
Shared-based compensation | — |  |  | — |  |  | 1,515 |  |  | — |  |  | — |  |  | — |  |  | 1,515 |  |  | — |  |  | 1,515 |
Other | — |  |  | — |  |  | — |  |  | 1 |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | — |
Distribution to noncontrolling interest | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (274) |  |  | (274) |
Comprehensive income (loss) | — |  |  | — |  |  | — |  |  | 13,466 |  |  | (12) |  |  | — |  |  | 13,454 |  |  | — |  |  | 13,454 |
BALANCES AT JUNE 29, 2023 | $ | 24,692 |  |  | $ | 7,078 |  |  | $ | 158,231 |  |  | $ | 275,157 |  |  | $ | (1,797) |  |  | $ | (1,919) |  |  | $ | 461,442 |  |  | $ | — |  |  | $ | 461,442 |
| Common Stock |  | Class B Common Stock |  | Capital in Excess of Par |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Treasury Stock |  | Shareholders’ Equity Attributable to The Marcus Corporation |  | Non- controlling Interest |  | Total Equity
BALANCES AT DECEMBER 30, 2021 | $ | 24,345 |  |  | $ | 7,130 |  |  | $ | 145,656 |  |  | $ | 289,306 |  |  | $ | (11,444) |  |  | $ | (1,379) |  |  | $ | 453,614 |  |  | $ | — |  |  | $ | 453,614 |
Exercise of stock options | — |  |  | — |  |  | (5) |  |  | — |  |  | — |  |  | 31 |  |  | 26 |  |  | — |  |  | 26 |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,373) |  |  | (1,373) |  |  | — |  |  | (1,373) |
Savings and profit-sharing contribution | 56 |  |  | — |  |  | 900 |  |  | — |  |  | — |  |  | — |  |  | 956 |  |  | — |  |  | 956 |
Reissuance of treasury stock | — |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | 8 |  |  | 9 |  |  | — |  |  | 9 |
Issuance of non-vested stock | 78 |  |  | — |  |  | (236) |  |  | — |  |  | — |  |  | 158 |  |  | — |  |  | — |  |  | — |
Shared-based compensation | — |  |  | — |  |  | 2,917 |  |  | — |  |  | — |  |  | — |  |  | 2,917 |  |  | — |  |  | 2,917 |
Other | — |  |  | — |  |  | 1 |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Conversions of Class B Common Stock | 19 |  |  | (19) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Comprehensive income (loss) | — |  |  | — |  |  | — |  |  | (14,902) |  |  | 531 |  |  | — |  |  | (14,371) |  |  | — |  |  | (14,371) |
BALANCES AT MARCH 31, 2022 | $ | 24,498 |  |  | $ | 7,111 |  |  | $ | 149,234 |  |  | $ | 274,403 |  |  | $ | (10,913) |  |  | $ | (2,555) |  |  | $ | 441,778 |  |  | $ | — |  |  | $ | 441,778 |
Exercise of stock options | — |  |  | — |  |  | (16) |  |  | — |  |  | — |  |  | 69 |  |  | 53 |  |  | — |  |  | 53 |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (104) |  |  | (104) |  |  | — |  |  | (104) |
Reissuance of treasury stock | — |  |  | — |  |  | (2) |  |  | — |  |  | — |  |  | 9 |  |  | 7 |  |  | — |  |  | 7 |
Issuance of non-vested stock | — |  |  | — |  |  | (305) |  |  | — |  |  | — |  |  | 305 |  |  | — |  |  | — |  |  | — |
Shared-based compensation | — |  |  | — |  |  | 1,655 |  |  | — |  |  | — |  |  | — |  |  | 1,655 |  |  | — |  |  | 1,655 |
Comprehensive income | — |  |  | — |  |  | — |  |  | 8,960 |  |  | 384 |  |  | — |  |  | 9,344 |  |  | — |  |  | 9,344 |
BALANCES AT JUNE 30, 2022 | $ | 24,498 |  |  | $ | 7,111 |  |  | $ | 150,565 |  |  | $ | 283,364 |  |  | $ | (10,529) |  |  | $ | (2,276) |  |  | $ | 452,733 |  |  | $ | — |  |  | $ | 452,733 |
Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:
| June 29, 2023 |  | December 29, 2022
Unrecognized gain on interest rate swap agreements | $ | — |  |  | $ | 80 |
Net unrecognized actuarial loss for pension obligation | (1,797) |  |  | $ | (1,774) |
| $ | (1,797) |  |  | $ | (1,694) |
Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability. The Company’s assets and liabilities measured at fair value are classified in one of the following categories: Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At June 29, 2023 and December 29, 2022, respectively, the Company’s $4,894 and $3,932 of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At June 29, 2023 and December 29, 2022, respectively, the Company’s $34,999 and $6,000 of investments in money market funds were valued using Level 1 pricing inputs and were included in cash and cash equivalents. Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At December 29, 2022, the Company’s $108 asset related to the Company’s interest rate swap contract was valued using Level 2 pricing inputs. This contracted terminated on March 1, 2023. Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At June 29, 2023 and December 29, 2022, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. The carrying value of the Company’s financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company’s $80,000 of senior notes, valued using Level 2 pricing inputs, is approximately $72,187 at June 29, 2023, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The fair value of the Company's $100,050 of convertible senior notes, valued using Level 2 pricing inputs, is approximately $150,020 at June 29, 2023, determined based on market rates and the closing trading price of the convertible senior notes as of June 29, 2023. The carrying amounts of the Company’s remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs. Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:
| 13 Weeks Ended |  | 26 Weeks Ended
| June 29, 2023 |  | June 30, 2022 |  | June 29, 2023 |  | June 30, 2022
Service cost | $ | 122 |  |  | $ | 264 |  |  | $ | 244 |  |  | $ | 528 |
Interest cost | 452 |  |  | 335 |  |  | 905 |  |  | 670 |
Net amortization of prior service cost and actuarial loss | (16) |  |  | 257 |  |  | (32) |  |  | 514 |
Net periodic pension cost | $ | 558 |  |  | $ | 856 |  |  | $ | 1,117 |  |  | $ | 1,712 |
Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings. Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 26 weeks ended June 29, 2023 is as follows:
| 13 Weeks Ended June 29, 2023
| Theatres |  | Hotels/Resorts |  | Corporate |  | Total
Theatre admissions | $ | 68,987 |  |  | $ | — |  |  | $ | — |  |  | $ | 68,987 |
Rooms | — |  |  | 28,646 |  |  | — |  |  | 28,646 |
Theatre concessions | 59,707 |  |  | — |  |  | — |  |  | 59,707 |
Food and beverage | — |  |  | 18,573 |  |  | — |  |  | 18,573 |
Other revenues(1) | 8,156 |  |  | 13,181 |  |  | 91 |  |  | 21,428 |
Cost reimbursements | — |  |  | 9,666 |  |  | — |  |  | 9,666 |
Total revenues | $ | 136,850 |  |  | $ | 70,066 |  |  | $ | 91 |  |  | $ | 207,007 |
| 26 Weeks Ended June 29, 2023
| Theatres |  | Hotels/Resorts |  | Corporate |  | Total
Theatre admissions | $ | 116,622 |  |  | $ | — |  |  | $ | — |  |  | $ | 116,622 |
Rooms | — |  |  | 46,503 |  |  | — |  |  | $ | 46,503 |
Theatre concessions | 102,082 |  |  | — |  |  | — |  |  | $ | 102,082 |
Food and beverage | — |  |  | 33,766 |  |  | — |  |  | $ | 33,766 |
Other revenues(1) | 14,522 |  |  | 26,414 |  |  | 180 |  |  | $ | 41,116 |
Cost reimbursements | — |  |  | 19,194 |  |  | — |  |  | $ | 19,194 |
Total revenues | $ | 233,226 |  |  | $ | 125,877 |  |  | $ | 180 |  |  | $ | 359,283 |
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers. The disaggregation of revenues by business segment for the 13 and 26 weeks ended June 30, 2022 is as follows:
| 13 Weeks Ended June 30, 2022
| Theatres |  | Hotels/Resorts |  | Corporate |  | Total
Theatre admissions | $ | 63,087 |  |  | $ | — |  |  | $ | — |  |  | $ | 63,087 |
Rooms | — |  |  | 28,865 |  |  | — |  |  | 28,865 |
Theatre concessions | 58,147 |  |  | — |  |  | — |  |  | 58,147 |
Food and beverage | — |  |  | 19,014 |  |  | — |  |  | 19,014 |
Other revenues(1) | 8,203 |  |  | 12,872 |  |  | 117 |  |  | 21,192 |
Cost reimbursements | — |  |  | 8,250 |  |  | — |  |  | 8,250 |
Total revenues | $ | 129,437 |  |  | $ | 69,001 |  |  | $ | 117 |  |  | $ | 198,555 |
| 26 Weeks Ended June 30, 2022
| Theatres |  | Hotels/Resorts |  | Corporate |  | Total
Theatre admissions | $ | 101,504 |  |  | $ | — |  |  | $ | — |  |  | $ | 101,504 |
Rooms | — |  |  | 46,295 |  |  | — |  |  | 46,295 |
Theatre concessions | 93,611 |  |  | — |  |  | — |  |  | 93,611 |
Food and beverage | — |  |  | 33,525 |  |  | — |  |  | 33,525 |
Other revenues(1) | 13,813 |  |  | 25,975 |  |  | 211 |  |  | 39,999 |
Cost reimbursements | — |  |  | 15,863 |  |  | — |  |  | 15,863 |
Total revenues | $ | 208,928 |  |  | $ | 121,658 |  |  | $ | 211 |  |  | $ | 330,797 |
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers. The Company had deferred revenue from contracts with customers of $37,670 and $37,046 as of June 29, 2023 and December 29, 2022, respectively. The Company had no contract assets as of June 29, 2023 and December 29, 2022. During the 26 weeks ended June 29, 2023, the Company recognized revenue of $10,875 that was included in deferred revenues as of December 29, 2022. During the 26 weeks ended June 30, 2022, the Company recognized revenue of $9,448 that was included in deferred revenues as of December 30, 2021. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program. As of June 29, 2023, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $1,980 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of June 29, 2023, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $16,318 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the next two years. As of June 29, 2023, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $3,834 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years. The majority of the Company’s revenue is recognized in less than one year from the original contract.

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 235 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//235/tableOfContent + Details
Name: | us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration